Divyansh Mangal, age 22, and Raksheet Jain, age 26, co-founded AI.gnosis in Jaipur in 2024, building India's first AI-powered autism and neurodevelopmental screening platform. A five-minute webcam-based test priced at ₹700, backed by 250 medical centres, validated by the Vice Chancellor of the Indian College of Pediatrics, backed by Google for Startups, and selected for Google's AI First Accelerator 2025, the startup secured ₹1 crore from three Sharks on Shark Tank India Season 4.
A Research Lab, a Social Mission, and the Realisation That Knowledge Without Access Changes Nothing
Divyansh Mangal's path to AI.gnosis began in research. He realised during his academic work that the knowledge and tools being developed had limited practical applications for the communities that needed them most. That gap between research capability and real-world impact became the founding frustration that led to AI.gnosis.
Raksheet Jain brought complementary depth spanning clinical understanding, operations, and the practical realities of how healthcare was delivered across India's diverse and often resource-constrained medical landscape.
Together, they founded AI.gnosis in 2024 in Jaipur, Rajasthan, with one founding mission: ensure that every child has the opportunity to thrive by meeting their developmental milestones, by identifying children who may be struggling early and providing the tools to enable timely interventions.
The Critical Gap in Early Detection
The founding insight was precise. Autism symptoms typically appear by age two. Early detection and intervention dramatically improve developmental outcomes. Yet the current diagnostic process in India requires specialist access, multiple visits, significant cost, and weeks of waiting.
For families in Tier 2 and Tier 3 cities, for families without health insurance, and for families without proximity to a paediatric specialist, early detection was effectively inaccessible.
AI.gnosis set out to change all of that with a five-minute AI-powered screening test priced at just ₹700, delivered from the comfort of home through a webcam-based assessment that required no specialist visit, no hospital appointment, and no waiting.
Webcam-Based Screening, Full Care Pathway, and a Platform Built Beyond Autism
The boldest product decision AI.gnosis made was to build not just a diagnostic tool but a complete care pathway, and to expand beyond autism from the very beginning.
The platform uses AI-powered webcam-based assessments to screen children for early signs of autism and developmental delays non-invasively from home. It offers comprehensive online assessments evaluating:
This diagnostic scope makes it one of the most comprehensive early childhood neurodevelopmental screening platforms available in India.
Structural Care Distribution (B2B and Clinical Network)
The care pathway extends beyond detection into therapeutic support, detailed reports, expert consultations, and therapy plans, all delivered through a B2B model partnering with 250 medical centres across India. This distribution model creates access at the point of care rather than requiring families to navigate specialist systems independently.
Institutional Validation & Global Recognition
The clinical validation behind the platform is institutional-grade. AI.gnosis is supported by Dr. S. Sitaraman, Vice Chancellor of the Indian College of Pediatrics, who has validated the company's approach, giving the platform the kind of medical authority that most early-stage healthtech startups spend years trying to earn.
In 2025, AI.gnosis was selected as one of only two healthtech startups admitted to Google's AI First Accelerator, a global programme recognising the most promising AI-first companies. Google for Startups and WTFund are confirmed investors in the company alongside the Shark Tank investors, confirming institutional confidence from both the world's most powerful technology company and India's most watched startup platform simultaneously.
Pre-Revenue, Three Sharks, and One Suggestion for a Government Award
AI.gnosis appeared on Shark Tank India Season 4 Episode 14 as a pre-revenue startup, making the outcome all the more extraordinary.
Divyansh and Raksheet entered seeking ₹50 lakh for 4% equity at a ₹12.5 crore valuation. Vineeta Singh stepped back specifically citing the company's pre-revenue status. Anupam Mittal appreciated the effort but chose not to invest. But Aman Gupta, Varun Dua, and Peyush Bansal were moved equally by the technology and the mission.
Aman Gupta publicly stated that if this issue is resolved, the founders ought to receive an award from the government, marking one of the most remarkable tributes ever paid to a startup on Indian national television.
The Final Shark Tank Deal Structure
After discussions, the three Sharks jointly offered ₹1 crore for 8% equity at a ₹12.5 crore valuation, doubling the capital the founders had asked for. Divyansh and Raksheet accepted, securing both funding and mentorship from three of India's most commercially and socially conscious investors, despite being pre-revenue at the time of filming.
Scale and Real-World Impact
| Business & Performance Category | Corporate Milestone Metric Details |
| Launch Framework | Founded in 2024 • Headquartered in Jaipur, Rajasthan |
| Ecosystem Conditions | Webcam-based AI assessments evaluating autism, ADHD, speech, cognitive, social functioning, and learning disabilities |
| Point of Care Reach | Active network operations running through 250 medical centres |
| Accessibility Unit Pricing | Cost fixed at ₹700 per 5-minute home screening session |
| Aggregate Seed Capital | Total funding raised is $151,000 across two rounds from six investors |
| Cap Table Composition | Includes 2 institutional investors and 4 angel investors |
| Anchor Venture Funds | Google for Startups and WTFund confirmed as primary platform backers |
| Shark Tank Round Closure | Angel round completed January 24, 2025 with Aman Gupta, Varun Dua, and Peyush Bansal |
| Human Resource Scale | 18 active employees deployed as of April 2026 |
| Strategic Global Accelerator | Selected for Google's AI First Accelerator 2025 (one of only two healthtech cohorts) |
| Direct Market Competitors | Spectrum AI, DAS Health, and Frontera Health |
The Most Powerful Technology Products Are the Ones That Solve a Problem Society Has Accepted as Unsolvable
The sharpest lesson from AI.gnosis's journey is this: the most transformative healthtech companies are the ones that take clinical knowledge that already exists and make it accessible to the people who need it most, at a price they can actually pay, in a format they can actually use.
Autism detection was not a knowledge problem in India. The tools and expertise existed. The barrier was access, cost, geography, and the intimidation of a specialist-dependent system. AI.gnosis addressed all of them simultaneously with a webcam-based, five-minute, ₹700 tool that a parent could use from home.
Aman Gupta said the founders deserved a government award. Google selected them for its global accelerator. Two hundred and fifty medical centres trusted them with their patients. All of this as a pre-revenue startup.
A 22-year-old. A 26-year-old. A research frustration. A webcam. And a mission to give every child in India the early intervention that could change the trajectory of their entire life. That is what building for impact looks like.
Sources: Zee Business, Crunchbase, PitchBook, LinkedIn, Startup Hyderabad, Tracxn, StartupArticle, Angeltors Blog
